Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.

Msaouel P, Hong AL, Mullen EA, Atkins MB, Walker CL, Lee CH, Carden MA, Genovese G, Linehan WM, Rao P, Merino MJ, Grodman H, Dome JS, Fernandez CV, Geller JI, Apolo AB, Daw NC, Hodges HC, Moxey-Mims M, Wei D, Bottaro DP, Staehler M, Karam JA, Rathmell WK, Tannir NM
Clin Genitourin Cancer. 2019 17 (1): 1-6

PMID: 30287223 · PMCID: PMC6348017 · DOI:10.1016/j.clgc.2018.09.005

MeSH Terms (10)

Carcinoma, Medullary Carcinoma, Renal Cell Clinical Trials as Topic Databases, Factual Eligibility Determination Humans Kidney Neoplasms Patient Selection Practice Guidelines as Topic Prognosis

Connections (1)

This publication is referenced by other Labnodes entities: